Springer Science and Business Media LLC
SCOPUS (2006-2009)
1544-1865
1544-225X
Cơ quản chủ quản: N/A
Phân tích ảnh hưởng
Các bài báo tiêu biểu
Androgen deprivation therapy and risk for diabetes and cardiovascular disease in prostate cancer survivors
Tập 6 - Trang 149-154 - 2008
Gonadotropin-releasing hormone (GnRH) agonists are the mainstay of treatment for
recurrent and metastatic prostate cancer. GnRH agonists are also an important
part of therapy for many men with localized or locally advanced prostate cancer.
Although GnRH agonists improve survival in certain settings, they involve
adverse effects including vasomotor flushing, obesity, and osteoporosis. This
article ...
Prescription versus herbal medications for prostate cancer prevention: Why history cannot be allowed to repeat itself in your clinical practice
Tập 3 Số 4 - Trang 160-168 - 2005
The use of prostate-specific antigen kinetics to stratify risk in prostate cancer
Tập 7 Số 1 - Trang 11-15 - 2009
Prostatitis: The cost of disease and therapies to patients and society
Tập 2 Số 1 - Trang 39-41 - 2004